EX-1.1
from 8-K
55 pages
Underwriting Agreement February 20, 2019 Deutsche Bank Securities Inc. Barclays Capital Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated Credit Suisse Securities (USA) LLC as Representatives of the Several Underwriters Listed in Schedule 1 Hereto C/O Deutsche Bank Securities Inc. 60 Wall Street New York, New York 10005 C/O Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 C/O Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 C/O Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010-3629 Ladies and Gentlemen: Eli Lilly and Company, an Indiana Corporation (The “Company”), Proposes to Issue and Sell to the Several Underwriters Listed in Schedule 1 Hereto (The “Underwriters”), for Whom You Are Acting as Representatives (The “Representatives”), $1,150,000,000 Principal Amount of Its 3.375% Notes Due 2029 (The “2029 Notes”), $850,000,000 Principal Amount of Its 3.875% Notes Due 2039 (The “2039 Notes”), $1,500,000,000 Principal Amount of Its 3.950% Notes Due 2049 (The “2049 Notes”) and $1,000,000,000 Principal Amount of Its 4.150% Notes Due 2059 (The “2059 Notes”), in Each Case Having the Terms Set Forth in Schedule 2 Hereto (Collectively, the “Securities”). the Securities Will Be Issued Pursuant to an Indenture Dated as of February 1, 1991 (As May Be Supplemented From Time to Time, the “Indenture”) Between the Company and Deutsche Bank
12/34/56
